ENTRY       D08857                      Drug
NAME        Anrukinzumab (USAN)
FORMULA     C6452H9954N1714O2024S46
EXACT_MASS  145301.5817
MOL_WEIGHT  145391.3306
SEQUENCE    (A chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFI SYAMSWVRQA PGKGLEWVAS ISSGGNTYYP
            DSVKGRFTIS RDNAKNSLYL QMNSLRAEDT AVYYCARLDG YYFGFAYWGQ GTLVTVSSAS
            TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPEALGAPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSREEMT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
            GNVFSCSVMH EALHNHYTQK SLSLSPGK
            (B chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFI SYAMSWVRQA PGKGLEWVAS ISSGGNTYYP
            DSVKGRFTIS RDNAKNSLYL QMNSLRAEDT AVYYCARLDG YYFGFAYWGQ GTLVTVSSAS
            TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPEALGAPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSREEMT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
            GNVFSCSVMH EALHNHYTQK SLSLSPGK
            (C chain)
            DIQMTQSPSS LSASVGDRVT ITCKASESVD NYGKSLMHWY QQKPGKAPKL LIYRASNLES
            GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQQSNEDPW TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (D chain)
            DIQMTQSPSS LSASVGDRVT ITCKASESVD NYGKSLMHWY QQKPGKAPKL LIYRASNLES
            GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQQSNEDPW TFGGGTKVEI KRTVAAPSVF
            IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS
            STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
            (Disulfide bridge: A22-A95, A145-A201, A221-C218, A227-B227, A230-B230, A262-A322, A368-A426, B22-B95, B145-B201, B221-D218, B262-B322, B368-B426, C23-C92, C138-C198, D23-D92, D138-D198)
  TYPE      Peptide
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
EFFICACY    Antiasthmatic, Anti-IL-13 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of asthma
TARGET      IL13 [HSA:3596] [KO:K05435]
BRITE       Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D08857  Anrukinzumab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL13
                 D08857  Anrukinzumab (USAN)
DBLINKS     CAS: 910649-32-0
            PubChem: 96025540
///
